ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
BankPosition in CRL — Charles River Laboratories International, Inc.
CIK 109380
SALT LAKE CITY, UT
Position in CRL
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$624,352
-$320,085 QoQ
Shares Held
2,753
-49.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#278
of 564 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ holds $6,737,592 across 19 Diagnostics & Research names. CRL ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
7,272 | $1,973,984 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
3,454 | $1,731,697 | |
| 3 | RDNT |
RadNet, Inc.
|
12,884 | $794,556 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
1,487 | $787,500 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,753 | $624,352 | |
| 6 | DHR |
Danaher Corp /De/
|
2,060 | $392,388 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
185 | $97,391 | |
| 8 | WAT |
Waters Corp /De/
|
161 | $60,381 |
All Filings in CRL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $624,352 | 2,753 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $944,437 | 5,475 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,897,453 | 9,512 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,585,878 | 10,136 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,748,233 | 11,522 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,588,437 | 10,553 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||